Aspirinworks Test Kit (11-DEHYDRO Thromboxane B2), Model 12136

FDA 510(k) K062025 · Corgenix, Inc.

Substantially Equivalent

510(k) numberK062025

Submission

Device name
Aspirinworks Test Kit (11-DEHYDRO Thromboxane B2), Model 12136
Applicant
Corgenix, Inc.
Broomfield, CO, US
Received
July 18, 2006
Decision date
May 29, 2007
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
OBW – 11-Dehydro Thromboxane B2 Kit, Urinary
Device class
Class II (moderate risk)
Regulation
21 CFR 864.5700
Specialty
Hematology

The test kit is an enzyme-linked immunoassay (elisa) to determine levels of 11-dehydro thromboxane b2 (11dhtxb2) in human urine, which aids in the qualitative detection of aspirin effect in apparently healthy individuals post ingestion. For professional use only.

More from Corgenix, Inc.

510(k)DeviceDecision
K072032Igg Anti-Atherox Test KitMSV · Traditional 04/04/2008SE
K042680Rhigene Hep-Ana Test SystemDHN · Traditional 11/19/2004SE
K032139Reaads Von Willebrand Factor Activity Test Kit, Model 10826GGP · Traditional 04/05/2004SE
K034013Reaads Dsdna Quantitative Test Kit, Model 022-001LKJ · Special 01/08/2004SE
K032868Reaads II Anti-Cardiolipin Igg Semi-Quantitative Test Kit, Model 11139MID · Special 10/14/2003SE
K031208Reaads Igm ANTI-B2GPI Test Kit, Model 038-001MSV · Special 07/07/2003SE
K024196Reeads Anti-Phosphatidylserine Igg/Igm Semi-Quantitative Test KitMID · Special 01/03/2003SE
K024195Modification to Reaads Anti-Phosphatidylserine Iga Semi-Quantative Test KitMID · Special 01/03/2003SE
K022992Reaads Anti-Cardiolipin Igg/Igm Semi-Quantitative Test Kit, Model 023-001MID · Special 09/25/2002SE
K022990Reaads Iga Anti-Cardiolipin Semi-Quantitative Test Kit, Model 026-001MID · Special 09/25/2002SE

Questions and answers

When was Aspirinworks Test Kit (11-DEHYDRO Thromboxane B2), Model 12136 cleared by the FDA?

Aspirinworks Test Kit (11-DEHYDRO Thromboxane B2), Model 12136 (K062025) received a 510(k) decision of Substantially Equivalent on May 29, 2007, 315 days after the submission was received.

What is the product code of K062025?

The FDA product code is OBW – 11-Dehydro Thromboxane B2 Kit, Urinary, a Class II (moderate risk) device regulated under 21 CFR 864.5700.